Hansen D S, Mestre F, Alberti S, Hernández-Allés S, Alvarez D, Doménech-Sánchez A, Gil J, Merino S, Tomás J M, Benedí V J
The International Escherichia and Klebsiella Reference Centre (WHO), Statens Serum Institut, and Department of Clinical Microbiology, Hvidovre Hospital, Copenhagen, Denmark.
J Clin Microbiol. 1999 Jan;37(1):56-62. doi: 10.1128/JCM.37.1.56-62.1999.
We have previously described an inhibition enzyme-linked immunosorbent assay method for the O typing of O1 lipopolysaccharide from Klebsiella pneumoniae which overcomes the technical problems and limitations of the classical O-typing method. In this study, we have extended the method to all of the currently recognized O types. The method was validated by studying the prototype strains that have defined the O groups by the classical tube agglutinatination O-typing method. Based on these results, we confirmed the O types of 60 of 64 typeable strains, and we propose a revised O-antigenic scheme, with minor but necessary changes, consisting of serogroups or serotypes O1, O2, O2ac, O3, O4, O5, O7, O8, and O12. Application of this typing method to 638 K. pneumoniae clinical isolates from Denmark, Spain, and the United States from different sources (blood, urine, and others) showed that up to 80% of these isolates belong to serotypes or serogroups O1, O2, O3, and O5, independently of the source of isolation, and that a major group of nontypeable isolates, representing about 17% of the total, consists of half O+ and half O- strains. Differences were observed, however, in the prevalence of the lipopolysaccharide O types or groups, depending on the country and isolation source.
我们之前描述了一种用于肺炎克雷伯菌O1脂多糖O分型的抑制酶联免疫吸附测定方法,该方法克服了经典O分型方法的技术问题和局限性。在本研究中,我们将该方法扩展到了所有目前公认的O型。通过研究那些用经典试管凝集O分型方法定义了O群的原型菌株,对该方法进行了验证。基于这些结果,我们确认了64株可分型菌株中60株的O型,并提出了一个修订后的O抗原方案,其中有一些微小但必要的变化,包括血清群或血清型O1、O2、O2ac、O3、O4、O5、O7、O8和O12。将这种分型方法应用于来自丹麦、西班牙和美国不同来源(血液、尿液等)的638株肺炎克雷伯菌临床分离株,结果显示,高达80%的这些分离株属于血清型或血清群O1、O2、O3和O5,与分离来源无关,并且一大类不可分型分离株(约占总数的17%)由一半O+和一半O-菌株组成。然而,根据国家和分离来源的不同,观察到脂多糖O型或O群的流行情况存在差异。